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Reducing the surgical complications 
of smoking by cotinine testing
To the Editor: We read with interest the edition of SAMJ (November 
2013) dedicated to smoking, arguably the most significant modifiable 
cause of death and disease. One of the areas not addressed relates 
to the impact of smoking in the context of surgery. It is well 
recognised that smoking increases the risk of overall complications, 
arrhythmias, thrombotic episodes, pneumonia, infection, wound 
healing complications and prolonged hospital stays, as well as the 
need for further surgery.[1-3] As surgeons we are frequently held 
responsible for these complications, and yet the decision to undertake 
the procedure at all should often be scrutinised, especially in the 
elective setting, rather than just the technical execution thereof.
Use of cotinine, a metabolite of nicotine, has been proposed to 
detect active smokers who claim not to smoke. This group may 
comprise as many as 34% of current smokers, which is not surprising 
considering the deceptive behaviour of people with addictions in 
general – in other words, up to a third of active smokers may lie about 
their smoking status. It has been demonstrated that smokers who 
CORRESPONDENCE
155       March 2014, Vol. 104, No. 3
developed wound healing complications had higher levels of cotinine 
than those who did not when tested peri-operatively.[1-3]
A study by Coon et al.[1] demonstrated that patients who claimed to 
have quit smoking were particularly likely to be deceitful, and a cost 
saving strategy may be employed whereby only this group is tested. 
In their cohort of plastic surgery patients, the test would detect 1 out 
of 10 ‘former’ smokers, as opposed to 1 in 66 of all patients in a self-
reported non-smoking population.
We believe that routine or selective serum or urine cotinine testing will 
enable us to stratify risk in both elective and reconstructive scenarios. 
Many procedures will therefore be cancelled, or at least delayed pending 
smoking cessation, which may have remarkable cost benefits for health 
systems, especially one as stretched as ours. Theatre time has been 
reduced in recent years despite increasing demand, and funding has 
inexplicably been diverted away from specialist surgical services.
The onus is on surgeons to be far stricter when applying absolute 
and relative contraindications, such as smoking, to elective surgery. 
Denying a patient a procedure s/he requires may also provide just the 
incentive needed to stop smoking.
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